Pricing
  1. US-listed companies
  2. Panbela Therapeutics, Inc.
  3. Raw

Panbela Therapeutics, Inc.【PBLA】

Market cap
$63.36K
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
General and administrative145,186197,575664,863333223565
Research and development-279,791-33322352821
Operating loss282,804-194,322-75,398-5-5-6-4-4-6-10-34-26
Interest income----------00
Gain on sale of intellectual property-----------0
Interest expense36,14335,89035,527002220000
Other expense----0-00-1-01-1-1-0
Total other expense----0-0-5-2-21-1-10
Loss before income tax benefit----------11-35-25
Income tax benefit284220121-1-0-1-0-0-0-0-0-0
Net loss247,380-212,021-107,044-5-5-1035-6-5-10-35-25
Foreign currency translation adjustment---00-000-111-0
Comprehensive loss----5-5-11-5-6-5-10-34-25
Basic and diluted net loss per share (in dollars per share)0.17-0.15---------67.91-316.52